The molecular mechanism of bisphenol A (BPA) as an endocrine disruptor by interacting with nuclear receptors: Insights from molecular dynamics (MD) simulations

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Li, Lanlan ^a   Wang, Qianqian ^a   Zhang, Yan ^a   Niu, Yuzhen ^b   Yao, Xiaojun ^b,c   Liu, Huanxiang ^a  

^a LANZHOU UNIVERSITY   (China)

^b LANZHOU UNIVERSITY   (China)

^c MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Macao)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; CELL NUCLEUS RECEPTOR; ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RELATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; UNCLASSIFIED DRUG; BENZHYDRYL DERIVATIVE; ESRRG PROTEIN, HUMAN; ESTROGEN; ESTROGEN RECEPTOR ALPHA; PHENOL DERIVATIVE; PROTEIN BINDING;

ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; HYDROGEN BOND; HYDROPHOBICITY; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; PROTEIN CONFORMATION; RECEPTOR BINDING; STRUCTURE ANALYSIS; AMINO ACID SEQUENCE; CHEMISTRY; HUMAN; METABOLISM; MOLECULAR DOCKING; MOLECULAR GENETICS;

AMINO ACID SEQUENCE; BENZHYDRYL COMPOUNDS; ESTROGEN RECEPTOR ALPHA; ESTROGENS, NON-STEROIDAL; HUMANS; MOLECULAR DOCKING SIMULATION; MOLECULAR DYNAMICS SIMULATION; MOLECULAR SEQUENCE DATA; PHENOLS; PPAR GAMMA; PROTEIN BINDING; RECEPTORS, ESTROGEN;

EID: 84925851254     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0120330     Document Type: Article

References (56)

1. Colborn T, vom Saal FS, Soto AM. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ Health Perspect. 2011; 101: 378-384.
2. Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, Hauser R, Prins GS, Soto AM, et al. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev. 2009; 30: 293-342. doi: 10.1210/er.2009-0002 PMID: 19502515
3. Bonefeld-Jorgensen EC, Long M, Hofmeister MV, Vinggaard AM. Endocrine-disrupting potential of bisphenol A, bisphenol A dimethacrylate, 4-n-nonylphenol, and 4-n-octylphenol in vitro: new data and a brief review. Environ Health Perspect 115 Suppl. 2007; 1: 69-76. doi: 10.1289/ehp.9368 PMID: 18174953
4. le Maire A, Bourguet W, Balaguer P. A structural view of nuclear hormone receptor: endocrine disruptor interactions. Cell Mol Life Sci. 2010; 67:1219-1237. doi: 10.1007/s00018-009-0249-2 PMID: 20063036
5. Tabb MM, Blumberg B. New modes of action for endocrine-disrupting chemicals. Mol Endocrinol. 2006; 20: 475-482. PMID: 16037129
6. Gao Y, Cao Y, Yang DG, Luo XJ, Tang YM, Li HM. Sensitivity and selectivity determination of bisphenol A using SWCNT-CD conjugate modified glassy carbon electrode. J Hazard Mater. 2012; 199:111-118. doi: 10.1016/j.jhazmat.2011.10.066 PMID: 22100222
7. Saiyood S, Vangnai AS, Thiravetyan P, Inthorn D. Bisphenol A removal by the Dracaena plant and the role of plant-associating bacteria. J Hazard Mater. 2010; 178: 777-785. doi: 10.1016/j.jhazmat.2010.02.008 PMID: 20304555
8. Tsai WT, Lee MK, Su TY, Chang YM. Photodegradation of bisphenol-A in a batch TiO2 suspension reactor. J Hazard Mater. 2009; 168: 269-275. doi: 10.1016/j.jhazmat.2009.02.034 PMID: 19285792
9. Vandenberg LN, Maffini MV, Wadia PR, Sonnenschein C, Rubin BS, Soto AM. Exposure to environmentally relevant doses of the xenoestrogen bisphenol - A alters development of the fetal mouse mammary gland. J Endocrinol. 2007; 148:116-127.
10. Zalko D, Jacques C, Duplan H, Bruel S, Perdu E. Viable skin efficiently absorbs and metabolizes bisphenol A. Chemosphere. 2011; 82: 424-430. doi: 10.1016/j.chemosphere.2010.09.058 PMID: 21030062
11. Delfosse V, Grimaldi M, Pons JL, Boulahtouf A, le Maire A, Cavailles V, et al. Structural and mechanistic insights into bisphenols action provide guidelines for risk assessment and discovery of bisphenol A substitutes. Proc Natl Acad Sci U SA. 2012; 109:14930-14935. doi: 10.1073/pnas.1203574109 PMID: 22927406
12. Rubin BS, Soto AM. Bisphenol A: Perinatal exposure and body weight. Mol Cell Endocrinol. 2009; 304: 55-62. doi: 10.1016/j.mce.2009.02.023 PMID: 19433248
13. Hunt PA, Lawson C, Gieske M, Murdoch B, Smith H, Marre A, et al. Bisphenol A alters early oogenesis and follicle formation in the fetal ovary of the rhesus monkey. Proc Natl Acad Sci USA. 2012; 109: 17525-17530. doi: 10.1073/pnas.1207854109 PMID: 23012422
14. Li QA, Li H, Du GF, Xu ZH. Electrochemical detection of bisphenol A mediated by [Ru(bpy)(3)](2+) on an ITO electrode. J Hazard Mater. 2010; 180: 703-709. doi: 10.1016/j.jhazmat.2010.04.094 PMID: 20494514
15. Gaido KW, Leonard LS, Lovell S, Gould JC, Babai D, Portier CJ, et al. Evaluation of Chemicals with Endocrine Modulating Activity in a Yeast-Based Steroid Hormone Receptor Gene Transcription Assay. Toxicol Appl Pharm. 1997; 143: 205-212.
16. Gould K, Leonard SL, Maness SC, Wagner BL, Conner K, Zacharewski T, et al. Bisphenol A interacts with the estrogen receptor α in a distinct manner from estradiol. Mol Cell Endocrinol. 1998; 142: 203-214. PMID: 9783916
17. Okada H, Tokunaga T, Liu XH, Takayanagi S, Matsushima A, Shimohigashi Y. Direct evidence revealing structural elements essential for the high binding ability of bisphenol A to human estrogen-related receptor-gamma. Environ Health Perspect. 2008; 116: 32-38. doi: 10.1289/ehp.10587 PMID: 18197296
18. Takayanagi S, Tokunaga T, Liu X, Okada H, Matsushima A, Shimohigashi Y. Endocrine disruptor bisphenol A strongly binds to human estrogen-related receptor gamma (ERRgamma) with high constitutive activity. Toxicol Lett. 2006; 167: 95-105. PMID: 17049190
19. Matsushima A, Kakuta Y, Teramoto T, Koshiba T, Liu X, Okada H, et al. Structural evidence for endocrine disruptorbisphenol A binding to human nuclear receptor ERR gamma. J Biochem. 2007; 142: 517-524. PMID: 17761695
20. Sui Y, Ai N, Park SH, Rios-Pilier J, Perkins JT, Welsh WJ, et al. Bisphenol A and its analogues activate human pregnane X receptor. Environ Health Perspect. 2012; 120: 399-405. doi: 10.1289/ehp.1104426 PMID: 22214767
21. Sohoni P, Sumpter JP. Several environmental oestrogens are also anti-androgens. J Endocrinol. 1998; 158: 327-339. PMID: 9846162
22. Riu A, Grimaldi M, le Maire A, Bey G, Phillips K, Boulahtouf A, et al. Peroxisome proliferator-activated receptor gamma is a target for halogenated analogs of bisphenol A. Environ Health Perspect. 2011; 119:1227-1232. doi: 10.1289/ehp.1003328 PMID: 21561829
23. Moriyama K, Tagami T, Akamizu T, Usui T, Saijo M, Kanamoto N, et al. Thyroid hormone action is disrupted by bisphenol A as an antagonist. J Clin Endocrinol Metab. 2002; 87: 5185-5190. PMID: 12414890
24. Zoeller RT, Bansal R, Parris C. Bisphenol-A, an environmental contaminant that acts as a thyroid hormone receptor antagonist in vitro, increases serum thyroxine, and alters RC3/neurogranin expression in the developing rat brain. J Endocrinol. 2005; 146:607-612.
25. Mckenna NJ, Lanz RB, O'malley BW. Nuclear Receptor Coregulators: Cellular and Molecular Biology. Endocr Rev. 1999; 20: 321-344. PMID: 10368774
26. Osz Judit, Yann Brélivet Carole Peluso-Iltis, Cura Vincent, Eiler Sylvia, Ruff Marc, et al. Structural basis for a molecular allosteric control mechanism of cofactor binding to nuclear receptors. Proc Natl Acad Sci USA. 2012; 109: 588-594. doi: 10.1073/pnas.1114966108 PMID: 22203987
27. Junichiro S, Pei LM, Evans RM. Nuclear receptors: Decoding metabolic disease. FEBS Letters. 2008; 582: 2-9. PMID: 18023286
28. Overington JP, Al-Lazikani B, Hopkins AL. How many drug targets are there? Nat rev Drug Discov. 2006; 5: 993-996. PMID: 17139284
29. Rubin BS. Bisphenol A: an endocrine disruptor with widespread exposure and multiple effects. J Steroid Biochem Mol Biol. 2011; 127: 27-34. doi: 10.1016/j.jsbmb.2011.05.002 PMID: 21605673
30. Xue W, Pan D, Yang Y, Liu H, Yao X. Molecular modeling study on the resistance mechanism of HCV NS3/4A serine protease mutants R155K, A156V and D168A to TMC435. Antivir Res. 2012; 93:126-137. doi: 10.1016/j.antiviral.2011.11.007 PMID: 22127068
31. Xue W, Ban Y, Liu H, Yao X. Computational study on the drug resistance mechanism against HCV NS3/4A protease inhibitors vaniprevir and MK-5172 by the combination use of molecular dynamics simulation, residue interaction network, and substrate envelope analysis. J Chem Inf Model. 2013; 54: 621-633. doi: 10.1021/ci400060j PMID: 23745769
32. Onufriev A, Bashford D, Case DA. Modification of the Generalized Born Model Suitable for Macromolecules. J Phys Chem. 2000; 104: 3712-3720.
33. Kollman PA, Massova I, Reyes C, Kuhn B, Huo SH, Chong L, et al. Calculating Structures and Free Energies of Complex Molecules: Combining Molecular Mechanics and Continuum Model. Acc Chem Res. 2000; 33: 889-897. PMID: 11123888
34. Massova I, Kollman PA. Combined molecular mechanical and continuum solvent approach (MM-PBSA/GBSA) to predict ligand binding. Perspect Drug Discov. 2000; 18:113-135.
35. Warnmark A, Treuter E, Gustafsson JA, Hubbard RE, Brzozowski AM, Pike ACW. Interaction of transcriptional intermediary factor 2 nuclear receptor box peptides with the coactivator binding site of estrogen receptor alpha. J Biol Chem. 2002; 277: 21862-21868. PMID: 11937504
36. Uppenberg J. Crystal Structure of the Ligand Binding Domain of the Human Nuclear Receptor PPAR-gamma. J Biol Chem. 1998; 273: 31108-31112. PMID: 9813012
37. Halgren TA, Murphy RB, Friesner RA, Beard HS, Frye LL, Pollard WT, et al. Glide: A New Approach for Rapid, Accurate Docking and Scoring. 2. Enrichment Factors in Database Screening. J Med Chem. 2004; 47:1750-1759. PMID: 15027866
38. Friesner RA, Murphy RB, Repasky MP, Frye LL, Greenwood JR, Halgren TA, et al. Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein-Ligand Complexes. J Med Chem. 2006; 49: 6177-6196. PMID: 17034125
39. Friesner RA, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, Repasky MP, et al. Glide: A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy. J Med Chem. 2004; 47:1739-1749. PMID: 15027865
40. Kumar R, Thompson EB. The structure of the nuclear hormone receptors. Steroids. 1999; 64: 310-319. PMID: 10406480
41. Bourguet W, Germain P, Gronemeyer H. Nuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological implications. Trends Pharmacol Sci. 2000; 21: 381-388. PMID: 11050318
42. Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, et al. Gaussian 09 software, Gaussian, Inc.: Wallingford, CT. 2009.
43. Fox T, Kollman PA. Application of the RESP Methodology in the Parametrization of Organic Solvents. J Phys Chem. 1998; 102: 8070-8079.
44. Cieplak P, Cornell WD, Bayly C, Kollman PA. Application of the Multimolecule and Multiconformational RESP Methodology to Biopolymers: Charge Derivation for DNA, RNA, and Proteins. J ComputChem. 1995; 16:1357-1377.
45. Bayly CI, Cieplak P, Cornell WD, Kollman PA. A Well-Behaved Electrostatic Potential Based Method Using Charge Restraints for Deriving Atomic Charges: The RESP Model. J Phys Chem. 1993; 97: 10269-10280.
46. Wang JM, Wolf RM, Caldwell JW, Kollman PA, Case DA. Development and Testing of a General Amber Force Field. J ComputChem. 2004; 25:1157-1174. PMID: 15116359
47. Wang JM, Cieplak P, Kollman PA. How Well Does a Restrained Electrostatic Potential (RESP) Model Perform in Calculating Conformational Energies of Organic and Biological Molecules? J Comput Chem. 2000; 21:1049-1074.
48. Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML. Comparison of simple potential functions for simulating liquid water. J Chem Phys. 1983; 79: 926-935.
49. Case DA, Cheatham TE, Darden T, Gohlke H, Luo R, Merz KM, et al. The Amber biomolecular simulation programs. J ComputChem. 2005; 26:1668-1688. PMID: 16200636
50. Deserno M, Holm C. How to mesh up Ewald sums. I. A theoretical and numerical comparison of various particle mesh routines. J Chem Phys. 1998; 109: 7678-7693.
51. Ryckaert JP, Ciccotti G, Berendsen HJC. Numerical integration of the cartesian equations of motion of a system with constraints molecular dynamics of n-alkanes. J Chem Phys. 1977; 23: 327-341.
52. Hou TJ, Yu R. Molecular dynamics and free energy studies on the wild-type and double mutant HIV-1 protease complexed with amprenavir and two amprenavir-related inhibitors: Mechanism for binding and drug resistance. J Med Chem. 2007; 50:1177-1188. PMID: 17300185
53. Xue WW, Pan DB, Yang Y, Liu HX, Yao XJ. Molecular modeling study on the resistance mechanism of HCVNS3/4A serine protease mutants R155K, A156V and D168A to TMC435. Antivir Res. 2012; 93: 126-137. doi: 10.1016/j.antiviral.2011.11.007 PMID: 22127068
54. Hou TJ, Zhang W, Wang J, Wang W. Predicting drug resistance of the HIV-1 protease using molecular interaction energy components. Proteins. 2009; 74: 837-846. doi: 10.1002/prot.22192 PMID: 18704937
55. Gouda H, Kuntz ID, Case DA, Kollman PA. Free energy calculations for theophyline binding to an RNA aptamer: Comparison of MM-PBSA and thermodynamic intergration methods. Biopolymers. 2003; 68: 16-34. PMID: 12579577
56. Sitkoff D, Sharp KM, Honig B. Accurate Calculation of Hydration Free Energies Using Macroscopic Solvent Models. J Phys Chem. 1994; 98:1978-1988.